相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines
Antoinette Hollestelle et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
The effect of thrombospondin-1 on breast cancer metastasis
Karen O. Yee et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Comment Re: MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?
Antoinette Hollestelle et al.
CANCER RESEARCH (2009)
MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?
Ann F. Chambers
CANCER RESEARCH (2009)
Thrombospondins in cancer
S. Kazerounian et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Molecular origins of cancer: Tumor angiogenesis
Robert S. Kerbel
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Kathy Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Current status in human breast cancer micrometastasis
Catherine Alix-Panabieres et al.
CURRENT OPINION IN ONCOLOGY (2007)
Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes
Taku Nakagawa et al.
CLINICAL CANCER RESEARCH (2007)
MDA-MB-435 cells are derived from M14 melanoma cells - a loss for breast cancer, but a boon for melanoma research
James M. Rae et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Angiogenesis as a therapeutic target
N Ferrara et al.
NATURE (2005)
The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein
R Simantov et al.
MATRIX BIOLOGY (2005)
The thrombospondins
CAA Josephine et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Lineage infidelity of MDA-MB-435 cells: Expression of melanocyte proteins in a breast cancer cell line
S Sellappan et al.
CANCER RESEARCH (2004)
Quantitative real-time PCR: a powerful ally in cancer research
S Mocellin et al.
TRENDS IN MOLECULAR MEDICINE (2003)
An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo
YH Noh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Quantification of human Alu sequences by real-time PCR - an improved method to measure therapeutic efficacy of anti-metastatic drugs in human xenotransplants
T Schneider et al.
CLINICAL & EXPERIMENTAL METASTASIS (2002)
Altered extracellular matrix remodeling and angiogenesis in sponge granulomas of thrombospondin 2-null mice
TR Kyriakides et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism
T Hawighorst et al.
EMBO JOURNAL (2001)
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
M Skobe et al.
NATURE MEDICINE (2001)
A novel member of the netrin family, β-netrin, shares homology with the β chain of laminin:: Identification, expression, and functional characterization
M Koch et al.
JOURNAL OF CELL BIOLOGY (2000)
The functions of thrombospondin-1 and-2
J Lawler
CURRENT OPINION IN CELL BIOLOGY (2000)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor
D Albo et al.
BRITISH JOURNAL OF CANCER (2000)
Systematic variation in gene expression patterns in human cancer cell lines
DT Ross et al.
NATURE GENETICS (2000)
Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
B Jimenez et al.
NATURE MEDICINE (2000)